Details of the Drug Combination
General Information of Drug Combination (ID: DC7IC1X)
Drug Combination Name |
Brincidofovir Brincidofovir
|
|||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Indication |
|
|||||||||||||||||
Component Drugs | Brincidofovir | Brincidofovir | ||||||||||||||||
Small molecular drug | Small molecular drug | |||||||||||||||||
2D MOL | 2D MOL | |||||||||||||||||
3D MOL is unavailable | 3D MOL is unavailable | |||||||||||||||||
High-throughput Screening Result | Testing Cell Line: KBM-7 | |||||||||||||||||
Zero Interaction Potency (ZIP) Score: 0.87 | ||||||||||||||||||
Bliss Independence Score: 0.87 | ||||||||||||||||||
Loewe Additivity Score: 4.67 | ||||||||||||||||||
LHighest Single Agent (HSA) Score: 4.69 | ||||||||||||||||||
References